A decade ago, Michael Ellis was one of San Diego’s highest-flying entrepreneurs. His company, Metabolife International, and its ephedra diet pill, Metabolife 356, were billion-dollar babies.

Today, Metabolife 356, like all other ephedra-based products, is banned by the U.S. Food and Drug Administration, and Metabolife International is a long-defunct company. And sometime this morning Michael Ellis will finish serving six months in prison for lying to the FDA about reports of serious health problems — like heart attacks, strokes and seizures — by consumers who took Metabolife 356.

But Ellis is coming out swinging.

Coinciding with Ellis’ release from prison is the release of “The Metabolife Story: The Rape of Cinderella.” The book is a “detailed account of the rise and fall of Metabolife, one of the most successful, yet ultimately unfairly characterized dietary supplement companies in history,” according to a promotional synopsis of the book.

Ellis’ publicist sent me a copy of the book and said he’ll try to get me an interview with Ellis sometime next week. I’ll peruse the book over the weekend just in case Ellis and I do talk. I’ll also re-read UT reporter Penni Crabtree’s 2003 investigation into Metabolife.


Leave a comment

We expect all commenters to be constructive and civil. We reserve the right to delete comments without explanation. You are welcome to flag comments to us. You are welcome to submit an opinion piece for our editors to review.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.